Dear Group Member,

 

My name is Aurélie, I am the Program Manager of the San Jose BioCenter, a $40,000  sq ft accelerator for high potential, high growth Bio-convergence companies. We conduct quarterly panels for our clients and entrepreneurs, these events are dedicated to bringing together a coalition of leading industry experts to discuss topics that are critical to the industry today. This year’s series will present the financing and partnership opportunities available to our burgeoning industry while examining how to identify, close and manage the right deal. Our Panel discussions are interactive, informal, and intend to be a conversation more than a presentation. We aim to get you something you can act on.

 

Our first 2008 Panel called “Sourcing and Negotiating Deals with Big BioPharma”  will take place on Thursday, March 20^th at 3:30pm. It is 90 minutes long with a “St Patrick” networking reception following. The goal is to bring in people from Big BioPharma, industry experts, and emerging companies that have an expertise either in Big Pharma investment fund, or in licensing, M&A, etc… Basically it aims to go over all the types of deals a small company can try to get with a bigger company. Please find a detailed description of the panel discussion below.

 

I’d like to invite all the members of the group to register at the Partner’s Network discount fee at http://www.acteva.com/booking.cfm?bevaid=151902.

 

I hope to see you there!

 

Best,

 

Aurélie

 

Aurélie Gaudin

Marketing & Programs Manager | San Jose BioCenter

www.sjbiocenter.com | 5941 Optical Court | San Jose, CA | 95138

B +33 253.45.57.39 | C +33 681.10.40.96 | E aurelie@...

 

*******************************************************

Sourcing and Negotiating Deals with Big BioPharma

A Panel & Networking Reception

Thursday March 20, 2008 @ the BioCenter

 

Agenda

3-3:30PM Networking, Registration, and Tour | 3:30-5PM Panel | 5-6:30PM St Patrick Networking Reception

From alliance to funding, Big Pharma and established biotech companies are increasingly investing in emerging companies. This Panel brings together executives from these larger companies to identify the type of deals now available to smaller companies, how to secure them, and how to manage them.

Questions that will be raised include:
• What are the best approaches for identifying a good partner?
• What type of partnerships are commonly used? And is your company a best candidate for a simple license, or a full blown joint venture, or a M&A?
• What about the rising of Big Pharma VC Funds?
• What are the strategies for attracting, securing and structuring strategic investments?
• How the Larger Bio-Companies’ needs differ from VCs’ needs?
• What are the key contract terms to be negotiated?
• What are the strategic reasoning behind different kinds partnerships?
• Effects on existing and potential future collaboration partners and other strategic decisions.
• Pros and cons of a small company partnering with a larger company.
• “Dos” and “don’ts” of managing these important relationships

 

Speakers

• S. Edward Torres, Managing Director, Lilly Ventures

• Suzy Jones, Senior Director, Business Development, Genentech, Inc.
• Sara M. Hall, Founder, Director & Chief Executive Officer, Tacere Therapeutics, Inc.
• Mohan Iyer, Managing Director, Merchant Banking, Burrill & Company
• David Summa, President & CEO, Acumen Pharmaceuticals
• Lead Facilitator: Scott M. Iyama, Corporate Lawyer, Emerging Companies Group Member, Orrick, Herrington & Sutcliffe LLP

 

Click here for speakers' bios and to read more about this event.

Cost & Registration
Pre-register at http://www.acteva.com/booking.cfm?bevaid=151902

• Regular Price: $60
• Partners' Network: $40
• BioCenter Members: Free
• On-site Registration: add $10 to the above (if space allows),